[go: up one dir, main page]

AU2001285026A1 - Methods and compositions for use in the diagnosis and treatment of chronic immune disease - Google Patents

Methods and compositions for use in the diagnosis and treatment of chronic immune disease

Info

Publication number
AU2001285026A1
AU2001285026A1 AU2001285026A AU8502601A AU2001285026A1 AU 2001285026 A1 AU2001285026 A1 AU 2001285026A1 AU 2001285026 A AU2001285026 A AU 2001285026A AU 8502601 A AU8502601 A AU 8502601A AU 2001285026 A1 AU2001285026 A1 AU 2001285026A1
Authority
AU
Australia
Prior art keywords
diagnosis
compositions
treatment
methods
immune disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001285026A
Inventor
Kenny Leo De Meirleir
Patrick Englebienne
C. V. Taylor Herst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Red Laboratories Nv
Original Assignee
R E D Lab N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R E D Lab N V filed Critical R E D Lab N V
Publication of AU2001285026A1 publication Critical patent/AU2001285026A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001285026A 2000-08-23 2001-08-16 Methods and compositions for use in the diagnosis and treatment of chronic immune disease Abandoned AU2001285026A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09645071 2000-08-23
US09/645,071 US6808936B1 (en) 2000-08-23 2000-08-23 Methods and compositions for use in the diagnosis and treatment of chronic immune disease
PCT/US2001/025796 WO2002015929A1 (en) 2000-08-23 2001-08-16 Methods and compositions for use in the diagnosis and treatment of chronic immune disease

Publications (1)

Publication Number Publication Date
AU2001285026A1 true AU2001285026A1 (en) 2002-03-04

Family

ID=24587528

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001285026A Abandoned AU2001285026A1 (en) 2000-08-23 2001-08-16 Methods and compositions for use in the diagnosis and treatment of chronic immune disease

Country Status (3)

Country Link
US (2) US6808936B1 (en)
AU (1) AU2001285026A1 (en)
WO (1) WO2002015929A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989239B2 (en) * 2001-06-20 2006-01-24 R.E.D. Laboratories, N.V./S.A. Methods for diagnosis and treatment of chronic immune diseases
WO2006026837A1 (en) * 2004-09-07 2006-03-16 Patrick Englebienne Diagnostic methods for measuring elastase activity levels
CN101175994A (en) * 2004-10-21 2008-05-07 药品诊断学公司 Stable metal/conductive polymer composite colloids and methods of making and using same
CA2740011A1 (en) * 2008-10-10 2010-04-15 Hemispherx Biopharma, Inc. Treatment of chronic fatigue syndrome using selective agonists of toll-like receptor 3 (tlr3)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6130206A (en) 1980-07-07 2000-10-10 Hem Research, Inc. Treating viral infections associated with chronic fatigue with dsRNA
WO1991000097A1 (en) 1989-06-27 1991-01-10 Hem Research, Inc. Diagnosing and treating viral infections associated with chronic fatigue
US5776690A (en) 1996-10-07 1998-07-07 Vojdani; Aristo Detection of chronic fatigue syndrome by decreased levels of RNase L inhibitor mRNA
US5985565A (en) 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US5830668A (en) 1996-12-13 1998-11-03 Immunosciences Lab, Inc. Detection of chronic fatigue syndrome
US6080554A (en) 1999-04-27 2000-06-27 R.E.D. Laboratories, N.V. Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject

Also Published As

Publication number Publication date
US20050009202A1 (en) 2005-01-13
US6808936B1 (en) 2004-10-26
WO2002015929A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
IL150628A0 (en) Use of lipid conjugates in the treatment of disease
AU2001271973A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2001236798A1 (en) Optically-active nanoparticles for use in therapeutic and diagnostic methods
AU2003243551A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2003291609A1 (en) Cb 1/cb 2 receptor ligands and their use in the treatment of pain
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
PT1757606E (en) Xanthinderivatives for use as medical agents and the preparation thereof
HUP0401023A3 (en) Use of flibanserin in the treatment of sexual disorders
HUP0400231A3 (en) Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
AU2002308348A1 (en) Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU2001264172A1 (en) Methods and compositions for diagnosing chronic immune disease
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU2002243363A1 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
AU2003286285A1 (en) Use of fgf-18 in the diagnosis and treatment of memory disorders
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003238242A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
HUP0400262A3 (en) Glycopeptides, their preparation and use in the treatment of multiple sclerosis
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
EP1472273A4 (en) Compositions and methods for the treatment of immune related diseases
AU2001285026A1 (en) Methods and compositions for use in the diagnosis and treatment of chronic immune disease
AU2001253886A1 (en) Methylxanthines in the diagnosis and treatment of autistic disorder
AU2003245858A1 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases